GKWIM
CLLS

Gerber Kawasaki Wealth & Investment Management’s Cellectis CLLS Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5
Closed – – 430
2021
Q3 		$0 Buy
+5
New +$69 ﹤0.01% 1178

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's CLLS Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 5 shares.

Gerber Kawasaki Wealth & Investment Management first reported a position in CLLS in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 5 Cellectis shares in Q4 2021.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Cellectis in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Cellectis position peaked at $0 in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.